IMP
Process View
glycosaminoglycan biosynthetic process
The chemical reactions and pathways resulting in the formation of glycosaminoglycans, any of a group of polysaccharides that contain amino sugars.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "glycosaminoglycan biosynthetic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| IL1R1 | interleukin 1 receptor, type I | 0.784 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.638 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.528 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.398 | ||
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.301 | Human | |
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.290 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.263 | Human | |
| HIP1 | huntingtin interacting protein 1 | 0.255 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.218 | ||
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.207 | Human | |
| FGA | fibrinogen alpha chain | 0.143 | ||
| NUMB | numb homolog (Drosophila) | 0.132 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.127 | Human | |
| BCL3 | B-cell CLL/lymphoma 3 | 0.088 | ||
| NRP1 | neuropilin 1 | 0.080 | ||
| ANGPT2 | angiopoietin 2 | 0.065 | Human | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.061 | Rat | |
| EGFR | epidermal growth factor receptor | 0.049 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.041 | Human | |
| TNIP2 | TNFAIP3 interacting protein 2 | 0.039 | ||
| PGF | placental growth factor | 0.038 | Human | |
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.036 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.036 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.030 | ||
| TOM1L1 | target of myb1 (chicken)-like 1 | 0.029 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.028 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.026 | ||
| NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0.026 | ||
| MAN1B1 | mannosidase, alpha, class 1B, member 1 | 0.025 | ||
| THBS1 | thrombospondin 1 | 0.025 | ||
| DKK1 | dickkopf homolog 1 (Xenopus laevis) | 0.022 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.021 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.020 | ||
| CNTF | ciliary neurotrophic factor | 0.020 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.020 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.019 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.018 | ||
| CAPRIN2 | caprin family member 2 | 0.018 | ||
| ENG | endoglin | 0.017 | ||
| ACSL4 | acyl-CoA synthetase long-chain family member 4 | 0.017 | ||
| AP2B1 | adaptor-related protein complex 2, beta 1 subunit | 0.017 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.015 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.015 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.015 | ||
| BMP1 | bone morphogenetic protein 1 | 0.015 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.015 | ||
| A2M | alpha-2-macroglobulin | 0.014 | ||
| OCRL | oculocerebrorenal syndrome of Lowe | 0.014 | ||
| DCN | decorin | 0.014 | ||
| IRS1 | insulin receptor substrate 1 | 0.014 | ||
| NOS1AP | nitric oxide synthase 1 (neuronal) adaptor protein | 0.014 | ||
| IL8 | interleukin 8 | 0.014 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.012 | ||
| STC1 | stanniocalcin 1 | 0.012 | ||
| SLIT2 | slit homolog 2 (Drosophila) | 0.012 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.012 | ||
| PRELP | proline/arginine-rich end leucine-rich repeat protein | 0.012 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.012 | ||
| VEGFC | vascular endothelial growth factor C | 0.012 | Human | |
| TMSB4X | thymosin beta 4, X-linked | 0.011 | ||
| CSPG4 | chondroitin sulfate proteoglycan 4 | 0.011 | ||
| PDGFC | platelet derived growth factor C | 0.011 | ||
| FNDC3B | fibronectin type III domain containing 3B | 0.011 | ||
| PARK2 | parkinson protein 2, E3 ubiquitin protein ligase (parkin) | 0.011 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.011 | ||
| B3GAT3 | beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) | 0.011 | ||
| SDF4 | stromal cell derived factor 4 | 0.011 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.011 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.011 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.011 | ||
| ARFGAP1 | ADP-ribosylation factor GTPase activating protein 1 | 0.010 | ||
| FGG | fibrinogen gamma chain | 0.010 | ||
| FCN2 | ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) | 0.010 | ||
| PIP5K1C | phosphatidylinositol-4-phosphate 5-kinase, type I, gamma | 0.010 |